1. Home
  2. CHEK vs AMZE Comparison

CHEK vs AMZE Comparison

Compare CHEK & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • AMZE
  • Stock Information
  • Founded
  • CHEK 2004
  • AMZE 2019
  • Country
  • CHEK Israel
  • AMZE United States
  • Employees
  • CHEK N/A
  • AMZE N/A
  • Industry
  • CHEK Medical Electronics
  • AMZE Beverages (Production/Distribution)
  • Sector
  • CHEK Health Care
  • AMZE Consumer Staples
  • Exchange
  • CHEK Nasdaq
  • AMZE Nasdaq
  • Market Cap
  • CHEK 4.3M
  • AMZE 5.2M
  • IPO Year
  • CHEK 2015
  • AMZE 2021
  • Fundamental
  • Price
  • CHEK $0.77
  • AMZE $10.00
  • Analyst Decision
  • CHEK
  • AMZE
  • Analyst Count
  • CHEK 0
  • AMZE 0
  • Target Price
  • CHEK N/A
  • AMZE N/A
  • AVG Volume (30 Days)
  • CHEK 19.6K
  • AMZE 71.2K
  • Earning Date
  • CHEK 08-14-2025
  • AMZE 08-13-2025
  • Dividend Yield
  • CHEK N/A
  • AMZE N/A
  • EPS Growth
  • CHEK N/A
  • AMZE N/A
  • EPS
  • CHEK N/A
  • AMZE N/A
  • Revenue
  • CHEK N/A
  • AMZE $254,711.00
  • Revenue This Year
  • CHEK N/A
  • AMZE N/A
  • Revenue Next Year
  • CHEK N/A
  • AMZE N/A
  • P/E Ratio
  • CHEK N/A
  • AMZE N/A
  • Revenue Growth
  • CHEK N/A
  • AMZE N/A
  • 52 Week Low
  • CHEK $0.56
  • AMZE $5.78
  • 52 Week High
  • CHEK $3.04
  • AMZE $28.72
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 45.27
  • AMZE N/A
  • Support Level
  • CHEK $0.71
  • AMZE N/A
  • Resistance Level
  • CHEK $0.77
  • AMZE N/A
  • Average True Range (ATR)
  • CHEK 0.03
  • AMZE 0.00
  • MACD
  • CHEK -0.00
  • AMZE 0.00
  • Stochastic Oscillator
  • CHEK 46.23
  • AMZE 0.00

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About AMZE Amaze Holdings Inc. Common Stock

Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.

Share on Social Networks: